HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-11-15
著者
-
Di Perri
Department Of Infectious Diseases University Of Turin Amedeo Di Savoia Hospital
-
Sciandra Mauro
Department Of Infectious Diseases University Of Turin Amedeo Di Savoia Hospital
-
Bonora Stefano
Department Of Infectious Diseases University Of Turin Amedeo Di Savoia Hospital
-
Baietto Lorena
Department Of Infectious Diseases University Of Turin Amedeo Di Savoia Hospital
-
Siccardi Marco
Department Of Infectious Diseases University Of Torino. Amedeo Di Savoia Hospital
-
Di Perri
Department Of Infectious Diseases University Of Torino. Amedeo Di Savoia Hospital
-
AVOLIO Antonio
Department of Infectious Diseases, University of Torino, Amedeo di Savoia Hospital
-
LORENA Baietto
Department of Infectious Diseases, University of Torino, Amedeo di Savoia Hospital
-
TRENTINI Laura
Department of Infectious Diseases, University of Torino, Amedeo di Savoia Hospital
-
D'avolio Antonio
Department Of Infectious Diseases University Of Turin Amedeo Di Savoia Hospital
-
D'avolio Antonio
Department Of Infectious Diseases University Of Torino. Amedeo Di Savoia Hospital
-
Sciandra Mauro
Department Of Infectious Diseases University Of Torino. Amedeo Di Savoia Hospital
-
Trentini Laura
Department Of Infectious Diseases University Of Torino Amedeo Di Savoia Hospital
関連論文
- Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients
- A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method
- Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds
- HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients
- New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma